Indications and uses
reduces underarm perspiration
reduces underarm perspiration
remove product cover turn dial at bottom to raise product apply to underarms only
| Active Ingredient | Purpose |
| Aluminum Zirconium Trichlorohydrex Glycine 20% | Antiperspirant |
For external use only
Consult a Doctor before use if you have kidney disease
immediately after shaving
on broken skin
on irritated skin
do not use in or near eyes
apply to underarms only
Stop use and ask a doctor if rash or irritation develops
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away
remove product cover
turn dial at bottom to raise product
apply to underarms only
cyclopentasiloxane, stearyl alcohol, mineral oil, hydrogenated castor oil, cetyl alcohol, diisopropyl adipate, aluminum starch octenylsuccinate, glyceryl stearate (and) PEG-100 stearate, fragrance, silica, PPG-14 butyl ether, talc
Questions? Call 1-844-923-7837
NEW LOOK!
CERTAIN DRI®
EVERYDAY STRENGTH CLINICAL
#1 Doctor recommended*
Effective protection for more certainty against odor & sweating
All day protection
SOLID
Antiperspirant | Deodorant
MORNING FRESH
NET WT 2.6 OZ. (74 g)
Who is Certain Dri® Everyday Strength Clinical for?
Anyone looking for certainty against odor and excessive sweating.
Directions: For maximum protection and efficacy, apply Certain Dri® Everyday Strength Clinical to each underarm before bed. Certain Dri® Everyday Strength Clinical works while you sleep, to help stop sweating before it starts. It can also be reapplied in the morning for an extra layer of freshness and deodorant protection. To reduce the risk of irritation, be sure underarms are completely dry before applying.
Learn more at:
www.certaindri.com
5004AB
Certain Dri® Everyday Strength Clinical helps stop excessive sweating for all day protection.
Doctors recommend Certain Dri®
by name more than any other clinical antiperspirant brand.*
Satisfaction Guaranteed.
If you are not completely satisfied, we will replace or refund your purchase.
If you have any questions, visit
www.certaindri.com or call 1-844-923-7837.
NEW LOOK!
Formerly known as: Certain Dri® A.M. Solid
*Based on a 2015 independent study, Certain Dri® is the #1 doctor recommended brand for excessive sweating.
Certain Dri® Everyday Strength Clinical helps stop excessive sweating for all day protection.
Distributed by: Clarion Brands, LLC
27070 Miles Rd., Suite A, Solon, OH 44139 ©2016

CERTAIN DRI®
EVERYDAY STRENGTH CLINICAL
#1 Doctor recommended*
Effective protection for more certainty against odor & sweating
All day protection
SOLID
Antiperspirant | Deodorant
MORNING FRESH
NET WT 2.6 OZ. (74 g)
2602B
Distributed by: Clarion Brands, LLC
27070 Miles Rd., Suite A, Solon, OH 44139 ©2016
2603B

| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aluminum Zirconium Trichlorohydrex Gly | ACTIVE INGREDIENT | T27D6T99LH | 2 | |
| Aluminum Zirconium Trichlorohydrex Gly | ACTIVE MOIETY | T27D6T99LH | 2 | |
| Aluminum Starch Octenylsuccinate | INACTIVE INGREDIENT | I9PJ0O6294 | 2 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 2 | |
| Diisopropyl Adipate | INACTIVE INGREDIENT | P7E6YFV72X | 2 | |
| Glyceryl Monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 2 | |
| Hydrogenated Castor Oil | INACTIVE INGREDIENT | ZF94AP8MEY | 2 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 2 | |
| Peg-100 Stearate | INACTIVE INGREDIENT | YD01N1999R | 2 | |
| Ppg-14 Butyl Ether | INACTIVE INGREDIENT | R199TJT95T | 2 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| Stearyl Alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 2 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69693-717 | 69693-717-26 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | EMULSION / TOPICAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / TOPICAL | 3.27 %w/w | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | GEL / TOPICAL | 150 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, EXTENDED RELEASE / ORAL | 244 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| Talc | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | GEL / TRANSDERMAL | 1.5 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LIQUID / TOPICAL | 1 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, DELAYED RELEASE / ORAL | 1337 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | CAPSULE, EXTENDED RELEASE / ORAL | 410.82 mg | ||
| Cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CAPSULE, EXTENDED RELEASE / ORAL | 72 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | AEROSOL, FOAM / TOPICAL | 200 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| Talc | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | CAPSULE, DELAYED RELEASE / ORAL | 3.1 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET / SUBLINGUAL | 1.6 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| Hydrogenated Castor Oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | LIQUID / TOPICAL | 0.24 %w/w | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| Peg-100 Stearate | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / VAGINAL | 100 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE / ORAL | 13.75 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / VAGINAL | 0.75 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / VAGINAL | 8 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d16c3144-bbfe-41cb-b65b-a9681409f69a | 97e05d41-6fbf-b7e2-184c-a126aa422a3a | 2016-10-06 | Warnings | 97e05d41-6fbf-b7e2-184c-a126aa422a3a |
Adverse event summaries are temporarily unavailable. Other product information remains available.